用于评估疑似急性冠脉综合征患者的髓过氧化物酶检测 - Suppr | 超能文献

Appraisal of myeloperoxidase for evaluation of patients with suspected acute coronary syndromes.

作者信息

Morrow David A

出版信息

J Am Coll Cardiol. 2007 May 22;49(20):2001-2. doi: 10.1016/j.jacc.2007.03.010. Epub 2007 May 4.

DOI:10.1016/j.jacc.2007.03.010

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Appraisal of myeloperoxidase for evaluation of patients with suspected acute coronary syndromes.用于评估疑似急性冠脉综合征患者的髓过氧化物酶检测

J Am Coll Cardiol. 2007 May 22;49(20):2001-2. doi: 10.1016/j.jacc.2007.03.010. Epub 2007 May 4.

2

High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study.高水平的系统性髓过氧化物酶与急性冠脉综合征患者的冠状动脉斑块糜烂有关：一项临床病理研究。

Circulation. 2010 Dec 14;122(24):2505-13. doi: 10.1161/CIRCULATIONAHA.110.955302. Epub 2010 Nov 29.

3

Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes.稳定型冠状动脉疾病和急性冠状动脉综合征患者的髓过氧化物酶水平。

Eur J Clin Invest. 2008 Feb;38(2):90-6. doi: 10.1111/j.1365-2362.2007.01908.x.

4

Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia.不稳定型心绞痛和急性心肌梗死患者的细胞内中性粒细胞髓过氧化物酶水平降低，但其降低与缺血无关。

J Am Coll Cardiol. 1996 Mar 1;27(3):611-6. doi: 10.1016/0735-1097(95)00524-2.

5

Neutrophil activation precedes myocardial injury in patients with acute myocardial infarction.在急性心肌梗死患者中，中性粒细胞激活先于心肌损伤。

Free Radic Biol Med. 2009 Jul 1;47(1):79-83. doi: 10.1016/j.freeradbiomed.2009.04.004. Epub 2009 Apr 9.

6

Levels of glutathione reductase and glutathione peroxidase of human platelets in unstable angina and myocardial infarction.不稳定型心绞痛和心肌梗死患者血小板中谷胱甘肽还原酶和谷胱甘肽过氧化物酶的水平

Boll Chim Farm. 1999 Sep;138(8):437-9.

7

Current role of myeloperoxidase in routine clinical practice.

Expert Rev Cardiovasc Ther. 2011 Feb;9(2):223-30. doi: 10.1586/erc.11.2.

8

Long-term survival after surgery for acute coronary syndromes in relation to perioperative troponin T release and angina class - a prospective study in 200 patients.急性冠状动脉综合征手术后的长期生存与围手术期肌钙蛋白T释放及心绞痛分级的关系——一项对200例患者的前瞻性研究

Thorac Cardiovasc Surg. 2009 Apr;57(3):148-52. doi: 10.1055/s-2008-1039217. Epub 2009 Mar 27.

9

Prognostic value of admission myeloperoxidase levels in patients with ST-segment elevation myocardial infarction and cardiogenic shock.ST段抬高型心肌梗死合并心源性休克患者入院时髓过氧化物酶水平的预后价值

Am J Cardiol. 2008 Jun 1;101(11):1537-40. doi: 10.1016/j.amjcard.2008.02.032. Epub 2008 Mar 26.

10

Letter by Schindhelm regarding article, "High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study".辛德海姆就“急性冠状动脉综合征患者全身髓过氧化物酶水平升高与冠状动脉斑块侵蚀相关：一项临床病理研究”一文所写的信。

Circulation. 2011 Jul 26;124(4):e143; author reply e144. doi: 10.1161/CIRCULATIONAHA.110.016642.

引用本文的文献

1

Multimarker Risk Stratification in Patients With Acute Myocardial Infarction.急性心肌梗死患者的多标志物风险分层

J Am Heart Assoc. 2016 May 20;5(5):e002586. doi: 10.1161/JAHA.115.002586.

2

Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes.髓过氧化物酶：缺血性心脏病和急性冠状动脉综合征中炎症的一种新生物标志物。

Mediators Inflamm. 2008;2008:135625. doi: 10.1155/2008/135625.

3

Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18.急性冠状动脉综合征中新型心脏生物标志物的联合评估：髓过氧化物酶和可溶性CD40配体以及TACTICS-TIMI 18研究中复发性缺血事件的风险

Eur Heart J. 2008 May;29(9):1096-102. doi: 10.1093/eurheartj/ehn071. Epub 2008 Mar 12.